Post by Tsung Tan

Agree to disagree with DORA Co-Intelligence article? Disagree I hope. Managing glioblastoma presents significant challenges due to its aggressive nature, high recurrence rates, and resistance to standard treatments. Clinical guidelines underscore the importance of extensive surgical removal, followed by adjuvant radiotherapy and chemotherapy, to enhance patient outcomes. Despite these efforts, the prognosis remains bleak, with a median survival period of around 15 months. My journey with GBM began back in November 2015 while working on Implantable Pumps for research involving lab animals. The image shared is a snapshot from that insightful presentation. By 2025, the pressing need for further advancements towards a cure became apparent, a reality that continues to hold true. Seeking new insights and updates on clinical trials in this field has become a personal pursuit. Utilizing various resources for this quest, I came across a compelling Co-Intelligence article from DORA by Insilico Medicine. Without altering its content, I intend to leverage this document as a foundational resource for expanding my knowledge in this critical area. #GBM #GlioblastomaMultiform #clinicaltrials Original Draft Post without "Rewrite with AI" ----------------------- "The management of glioblastoma remains a formidable challenge due to its aggressive nature, high recurrence rates, and resistance to conventional therapies. Key clinical principles emphasize the importance of maximal safe surgical resection followed by adjuvant radiotherapy and chemotherapy, which have been shown to improve patient outcomes. However, the prognosis remains poor, with a median survival of approximately 15 months." excerpt from conclusions. I first learnt about GBM in November 2015 when I started working on Implantable Pumps for research purposes in lab animals. Image is actually actually from the presentation itself. In 2025, I also "knew" that much more needed to be done to find a cure. Unfortunately, proven to be true. Currently looking for new learnings and clinical trials in this area for personal reasons. I have been using different tools for this. This is a Co-Intelligence article from DORA by Insilico Medicine. I have not changed anything and will be using it as a base document to learn more. Here are 2 charities which have a lot of validated resources. Both UK based. Brain Tumour Research Brain Tumour Research #GBM #GlioblastomaMultiform #clinicaltrials #CoIntelligence